Methods of treating diabetic cardiomyopathy using glycogen...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S004300, C514S252140, C514S253030, C514S323000, C514S330000, C514S018700, C514S415000, C540S229000

Reexamination Certificate

active

06867184

ABSTRACT:
The present invention provides methods of treating diabetic cardiomyopathy, the methods comprising administering to a patient having or at risk of having diabetic cardiomyopathy a therapeutically effective amount of a glycogen phosphorylase inhibitor. The present invention also provides methods of treating diabetic cardiomyopathy, the methods comprising administering to a patient having 1) diabetes and 2) having cardiovascular disease, ischemic heart disease, congestive heart failure, congestive heart failure but not having coronary arteriosclerosis, hypertension, diastolic blood pressure abnormalities, microvascular diabetic complications, abnormal left ventricular function, myocardial fibrosis, abnormal cardiac function, pulmonary congestion, small vessel disease, small vessel disease without atherosclerotic cardiovascular disease or luminal narrowing, coagulopathy, cardiac contusion, or having had or at risk of having a myocardial infarction a therapeutically effective amount of a glycogen phosphorylase inhibitor.

REFERENCES:
patent: 4786641 (1988-11-01), Goldmann et al.
patent: 5990111 (1999-11-01), Johnson
patent: 5998463 (1999-12-01), Hulin et al.
patent: 6277877 (2001-08-01), Hoover et al.
patent: 6294538 (2001-09-01), Mylari
patent: 0846464 (1997-12-01), None
patent: 0884050 (1998-12-01), None
patent: 0 978 279 (2000-02-01), None
patent: 1 088 824 (2001-04-01), None
patent: WO9524391 (1995-09-01), None
patent: WO9639384 (1996-12-01), None
patent: WO9639385 (1996-12-01), None
patent: WO9709040 (1997-03-01), None
patent: WO9731901 (1997-09-01), None
patent: WO0880964 (1998-05-01), None
patent: WO9840353 (1998-09-01), None
patent: WO9850359 (1998-11-01), None
patent: WO9926659 (1999-06-01), None
patent: WO 0168055 (2001-09-01), None
patent: WO 0168092 (2001-09-01), None
patent: WO 0220530 (2002-03-01), None
Bell, David S. H.,Diabetic Cardiomyopathy: A unique entity or a complication of coronary artery disease?, Diabetes Care, vol. 18, No. 5, 708-714, May 1995.
Fein, Frederick S., et al.,Diabetic Cardiomyopathy, Cardiovascular Drugs and Therapy, 1994; 8:65-73.
Hoover, Dennis J., et al.,Indole-2-carboxamide Inhibitors of Human Liver Glycogen Phosphorylase, American Chemical Society, 1998, 41, 2934-2938.
Martin, et al., “Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo”,Proc. Natl. Acad. Sci., 95:1776-1781 (1998).
European Search Report, Application No. 01 300 575.6-2123, dated Dec. 19, 2003.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treating diabetic cardiomyopathy using glycogen... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating diabetic cardiomyopathy using glycogen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating diabetic cardiomyopathy using glycogen... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3458402

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.